Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P110002/S038

Mobi-C Cervical Disc Prosthesis

Highridge Medical, LLC · Decision date Mar 23, 2026

FDA DECISIONP110002/S038

What did the FDA decide?

FDA records P110002/S038 as a supplement to PMA P110002, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Mar 23, 2026.

FDA approval order statement

addition of a new raw material supplier (IKH) for titanium powder used in the plasma spray coating of Mobi-C inferior and superior endplates, and qualification of a back-up final cleaning line (HAMO 210 #LA2165) for cleaning of Mobi-C inserts and jaws performed at the same Viant facility
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Orthopedic
Decision date
Mar 23, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P110002/S038
Regulatory pathway
PMA supplement
Product code
MJO
Decision code
OK30
Decision date
Mar 23, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, intervertebral disc.

Product code
MJO
FDA device class
3

For the original device and its historical approval scope, see PMA P110002. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P110002 · Original PMA

    MOBI-C CERVICAL DISC PROSTHESIS (ONE-LEVEL INDICATION)

  2. P110002/S037 · Related supplement

    LDR Spine Mobi-C Cervical Disc Prosthesis

  3. P110002/S038 received

    Application receipt date recorded by FDA.

  4. P110002/S038 · FDA decision

    30-Day Notice

  5. P110002/S040 · Related supplement

    Mobi-C Cervical Disc Prosthesis for use at One Level

Timeline entries are records held by MedtechLedger for P110002. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P110002

Product / regulatory recordCompanyPathwayDecision dateSource
Highridge Medical, LLCPMA approvalAug 7, 2013FDA
Highridge Medical, LLCPMA supplementOct 29, 2025FDA
Highridge Medical, LLCPMA supplementSep 16, 2026FDA

Explore the linked device profile

Other records with product code MJO

Product / regulatory recordCompanyPathwayDecision dateSource
Spineart USA, Inc.PMA supplementSep 22, 2026FDA
Synergy DiscP250028/S003
Synergy Spine Solutions, Inc.PMA supplementSep 17, 2026FDA
Highridge Medical, LLCPMA supplementSep 16, 2026FDA
prodisc C NovaP070001/S031
Centinel Spine, LLCPMA supplementSep 9, 2026FDA
Spineart USA, Inc.PMA supplementAug 27, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Highridge Medical, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
10225 Westmoor Dr., Westminister, CO, 80021

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records